Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)
CNY 21.01
(1.84%)
CNY 21.01
(1.84%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 127.68 Million CNY | 360.49% |
| 2022 | 27.72 Million CNY | 70.88% |
| 2021 | 16.22 Million CNY | 206.03% |
| 2020 | 5.3 Million CNY | -81.98% |
| 2019 | 29.42 Million CNY | -21.27% |
| 2018 | 37.37 Million CNY | 712.08% |
| 2017 | 4.6 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 24.33 Million CNY | -48.31% |
| 2024 Q1 | 67.55 Million CNY | 139.77% |
| 2024 Q2 | 47.08 Million CNY | -30.3% |
| 2023 Q2 | 85.92 Million CNY | 2027.12% |
| 2023 FY | 127.68 Million CNY | 360.49% |
| 2023 Q3 | 9.55 Million CNY | -88.89% |
| 2023 Q1 | 4.03 Million CNY | -44.7% |
| 2023 Q4 | 28.17 Million CNY | 195.03% |
| 2022 Q3 | 9.36 Million CNY | 34.12% |
| 2022 Q2 | 6.98 Million CNY | 71.74% |
| 2022 Q1 | 4.06 Million CNY | -26.28% |
| 2022 FY | 27.72 Million CNY | 70.88% |
| 2022 Q4 | 7.3 Million CNY | -22.05% |
| 2021 FY | 16.22 Million CNY | 206.03% |
| 2021 Q4 | 5.51 Million CNY | 40.54% |
| 2021 Q3 | 3.92 Million CNY | -39.53% |
| 2021 Q2 | 6.49 Million CNY | 2144.21% |
| 2021 Q1 | 289.31 Thousand CNY | -59.99% |
| 2020 Q4 | 723.16 Thousand CNY | -80.42% |
| 2020 Q3 | 3.69 Million CNY | 0.0% |
| 2020 FY | 5.3 Million CNY | -81.98% |
| 2019 FY | 29.42 Million CNY | -21.27% |
| 2018 FY | 37.37 Million CNY | 712.08% |
| 2017 FY | 4.6 Million CNY | 0.0% |